Service de Chirurgie Digestive, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France,
Faculté de Médecine de Lyon, Université Claude Bernard Lyon 1 (UCBL1), Lyon, France,
Dig Surg. 2020;37(1):47-55. doi: 10.1159/000496510. Epub 2019 Feb 22.
Implementation of enhanced recovery after surgery (ERAS) program after pancreatic surgery was associated with decreased length of stay (LOS). However, there were only retrospective uncontrolled before-after study, and care protocols were heterogeneous. We aimed to evaluate the impact of ERAS program on postoperative outcomes after pancreatectomy through a prospective controlled study.
A before/after study with a contemporary control group was undertaken in patients undergoing pancreatectomy. We compared 2 groups: the intervention hospital that implemented ERAS program and the control hospital that performed traditional care; and 2 periods: the preimplementation and the post-implementation period. A difference-in-differences approach was used to evaluate whether implementation of ERAS program was associated with improved LOS and postoperative morbidity.
About 97 and 75 patients were included in intervention and control hospital. In multivariate analysis, implementation of ERAS was associated with a significantly shorten LOS (hazard ratio 1.61; 95% CI 1.07-2.44) and higher compliance rate (OR 1.34; 95% CI 1.18-1.53). Difference-in-differences analysis revealed that LOS, morbidity, and readmission did not differ after ERAS implementation.
Implementation of ERAS program was safe and effective after pancreatectomy with high compliance rate. LOS was significantly reduced without compromising morbidity.
胰腺手术后实施加速康复外科(ERAS)方案与住院时间(LOS)缩短有关。然而,仅有回顾性非对照的前后研究,且护理方案存在异质性。我们旨在通过前瞻性对照研究评估 ERAS 方案对胰腺切除术后结局的影响。
在接受胰腺切除术的患者中进行了一项前后研究,并设立了同期对照组。我们比较了两组:实施 ERAS 方案的干预医院和实施传统护理的对照组医院;以及两个时期:实施前和实施后。采用差值法评估 ERAS 方案的实施是否与 LOS 和术后发病率的改善相关。
干预医院和对照组医院分别纳入了约 97 例和 75 例患者。多变量分析显示,实施 ERAS 与 LOS 显著缩短相关(风险比 1.61;95%CI 1.07-2.44),且依从性更高(比值比 1.34;95%CI 1.18-1.53)。差值分析显示,ERAS 实施后 LOS、发病率和再入院率无差异。
胰腺切除术后实施 ERAS 方案安全有效,且依从性高。LOS 显著降低,而发病率无恶化。